📰 Ognitive Function News
Page 36 - Ognitive Function News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ognitive Function. Real-time updates on events, politics, business and more.
August 18, 2023
Daily supplementation with collagen peptides may boost not only functional and physical outcomes for middle-aged people but may also significantly improve measures of pain and mental health, says a new double-blind, placebo-controlled, randomized study.
August 18, 2023
Pre-workout ingredient PeakATP may have extended post-workout effects, according to a recent study reporting cognitive benefits following high-intensity sprint exercise.
August 17, 2023
Pre-workout ingredient PeakATP may have extended post-workout effects, according to a recent study reporting cognitive benefits following high-intensity sprint exercise.
August 16, 2023
July 2023 was the hottest month on record, with cities like Phoenix experiencing record-breaking heat waves for weeks on end.
August 16, 2023
Dr. Heather Sandison, a leading expert in Alzheimer's Disease and Related Dementia (ADRD) care, has recently published a groundbreaking study in the Journal of Alzheimer's Disease, highlighting significant improvements in cognitive function among individuals with cognitive decline.
August 16, 2023
Daily supplementation with Probi’s HEAL9 probiotic strain may improve learning and working memory in healthy adults, says a new study from Sweden.
August 16, 2023
Norwegian delivery innovator Vitux has opened its first North American production facility to better meet growing global demand for its Smart Chew jelly-like matrix system.
August 14, 2023
The startup HealthyLonger is shining a light on the lack of objectivity in the treatment of mental health conditions, offering at-home urine tests to identify potential neuro-biomarker disruptions and nutrient deficiencies.
August 14, 2023
Researchers examine the association between time in range, a glycemic metric, and cognitive impairment in patients with type 2 diabetes
August 10, 2023
The Norwegian fishing and biotech company has successfully achieved New Dietary Ingredient (NDI) status from the US Food and Drug Administration for its Lysoveta. Under the NDI, Aker BioMarine can market Lysoveta at 1.5 grams/day for the general adult population.